Oliver Freudenreich, MD, FACLP
a:2:{i:0;s:79:"Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts";i:1;s:45:"Harvard Medical School, Boston, Massachusetts";}
Case Report
Comprehensive Evaluation Detects Seizure Disorder That Exacerbated Catatonia and Treatment-Resistant Schizophrenia
December 22, 2022
In this young man, continuous video-EEG monitoring revealed undiagnosed seizures that, once treated, helped resolve his catatonia and reduce symptoms of schizophrenia.
Brief Report
Long-Acting Injectable Antipsychotic Management During COVID-19
January 12, 2021
Long-acting injectable antipsychotics are effective for preventing relapse in schizophrenia, but in-person administration of them is a challenge during a pandemic. This report describes how a clinic successfully reduced...
Letter to the Editor
Lamotrigine Cross-Reactivity With Phencyclidine in a Research Study
July 26, 2018
Routine urine drug screening in research trials is an underappreciated risk for trial participants. Here, the authors present a case of lamotrigine cross-reactivity with phencyclidine in a clinical trial...
